Advertisement Pharmaceutical Business review - Page 1344 of 5287 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
August 21, 2026

Charles River and MVC to develop enterovirus vaccine

Charles River Laboratories International and Medigen Vaccine Biologics (MVC) have entered a collaboration to support the characterisation along with validation of the virus seed bank for the latter’s next-generation multivalent enterovirus vaccine.

The collaboration seeks to leverage the global expertise that Charles River provides in areas such as biologics testing. Credit: Wasan Tita / Shutterstock.com.